Biopharma Daily Stock Updates - 03/31/21

$XBI $135.65 +4%

Pipeline Updates

$BTAI -3% Ph 1b/2 data. source


$AVXL +6% Interim DSMB recommendation to continue ph 2b/3 study. source


$CTIC -2% Completes rolling NDA for pacritinib for myelofibrosis. source


$SNDX +7% Orphan Drug granted. source


$EXEL +3% EU approval of Cabometyx + Opdivo. source


Finance Updates

$ CTIC -2% Offering. source

0 comments

*Disclaimer: Information provided on bpiq.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.

SITE